About
Monday Noon seminars are hosted by the Hope Center and the Department of Neurology. Talks are organized around mini-series topics; each mini-series is organized by Hope Center faculty members to feature investigators from Washington University as well as one outside speaker. Monday Noon seminars run during the academic year, typically September through May.
All seminars are listed on the Office of Neuroscience Research (ONR) Calendar.
For inquiries, contact John Cirrito or Cindy Lawrence.
Mini-Series Topics:
Complement in Neurodegeneration
Amyotrophic Lateral Sclerosis (ALS)
Microbiome and Neurological Disease
G protein-coupled receptors in health and diseases
Neurodegeneration of the Retina
Development and Disorders of the Peripheral Nervous System (Joint series with Developmental Biology)
2021/2022 Monday Noon Seminars
Mondays, 12-1p
September – June
Zoom conference
Complement in Neurodegeneration
Organizers, Erik Musiek and Pat Sheehan (WashU Neurology)
- September 27: Hrishikesh Kulkarni (WashU Medicine) “Local complement activation in inflammation and injury”
- October 4: Hui Zheng (Baylor College of Medicine) “Complement C3 and C3aR signaling in vascular aging and Alzheimer’s disease”
- October 11: Michael Carroll (Harvard Medical School) “Over expression of schizophrenia susceptibility factor C4A promotes excessive synaptic loss and alteration in behavior”
- November 1: Robyn Klein (WashU Medicine) “Learning from viruses: Complement and memory”
Amyotrophic Lateral Sclerosis (ALS)
Organizer, Timothy Miller (WashU Neurology)
- November 22: Timothy Miller (WashU Neurology) “Precision Medicine for ALS”
- November 29: Aaron DiAntonio (WashU Developmental Biology) “The SARM1 Axon Degeneration Pathway: Implications for ALS pathogenesis and therapy”
- December 6: Adrian Isaacs (University College London) “Dissecting disease-causing mechanisms in C9orf72 FTD/ALS”
- December 13: Sami Barmada (University of Michigan Health System) “Dr. Jekyll and Mr. Hyde: The strange case of TDP43 isoforms in ALS and FTD”
- December 20: Yuna Ayala (Saint Louis University) “What gets TDP-43 into trouble? Understanding the connection between TDP-43 function and ALS pathogenesis”
Microbiome and Neurological Disease
Organizers, David Holtzman and Dong-oh Seo (WashU Neurology)
- January 10: Sangram Sisodia (University of Chicago) “Role of the Gut Microbiome in the Pathogenesis of Alzheimer’s Disease”
- January 24: Brian Kim (Mount Sinai; formerly WashU Medicine) “Neuroimmune Regulation of Itch”
- January 31: Beau Ances (WashU Neurology) “The Gut Microbiome in Neurodegenerative Diseases”
- February 7: John Fryer (Mayo Clinic) “Good bugs gone bad: Bacterial influences on neurological health and disease”
- February 14: Dong-oh Seo (Holtzman lab, WashU Neurology) “Evidence that the gut microbiota regulates progression of neurodegeneration in a mouse model of tauopathy, in a sex- and ApoE isoform-dependent manner”
G protein-coupled receptors in health and diseases
Organizer, Yao Chen (WashU Neuroscience)
- February 21: Karen O’Malley (WashU Neuroscience) “Location, location, location…site-specific GPCR signaling generates unique functional outcomes”
- February 28: Talia Lerner (Northwestern University) “Glucocorticoid Regulation of Dopamine Transmission”
- March 7: Jordan McCall (WashU Anesthesiology) “Stress-induced plasticity in noradrenergic analgesia”
- March 14: Matthew Banghart (University of California, San Diego) “Convergent mechanisms for pharmacological and cognitive pain modulation”
- March 21: Tao Che (WashU Anesthesiology) “Structure-guided Design of Safer Opioid Analgesics”
Neurodegeneration of the Retina
Organizer, Philip Williams (WashU Ophthalmology & Visual Sciences)
- March 28: Bo Chen (Icahn School of Medicine at Mount Sinai) “Neuroprotective and Regenerative Strategies for Vision Restoration”
- April 4: Rajendra Apte (WashU Ophthalmology & Visual Sciences) “Metabolism and Retinal Neurodegeneration”
- April 11: Thomas Reh (University of Washington) “Reprogramming Muller glia for retinal repair: Never too late to change their fate”
- April 18: Daniel Kerschensteiner (WashU Ophthalmology & Visual Sciences) “Understanding and protecting the human retina”
Development and Disorders of the Peripheral Nervous System
Joint series with the Department of Developmental Biology
Organizers, Mayssa Mokalled and Tony Tsai (WashU Developmental Biology)
Kindly note this mini-series is HYBRID. The in-person location is Connor Auditorium (Farrell LTC, Medical Campus).
- May 2: Alison Snyder-Warwick (WashU Surgery) “Focusing on the motor target: The role of the neuromuscular junction in recovery after nerve injury”
- May 9: Rejji Kuruvilla (Johns Hopkins University) “Sympathetic nervous system development and functions”
- May 16: Valeria Cavalli (WashU Neuroscience) “Satellite Glial Cells in sensory nervous system health, injury and disease”
- May 23: Stefanie Geisler (WashU Neurology) “Chemotherapy-induced neuropathy: From bedside to bench and back”
Special Seminars
Kindly note that this seminar will be via Zoom. Stay tuned for Zoom information (WUSTL Key required).
- June 6: VIRTUAL Hope Center Awards Seminar
- Dana Shaw (Mokalled lab, WashU Developmental Biology) “An intricate immune balance necessary for natural spinal cord regeneration”
- Alexandra Litvinchuk (Holtzman lab, WashU Neurology) “The relationship between ApoE and lipid dysregulation in glia of the PS19 mouse model of tauopathy”
Suggest a Mini-Series Topic
Submit by March 29, for the upcoming 2022/2023 season!
Please keep in mind:
- Anyone (PI or lab member) can suggest topics.
- Each mini-series typically includes three speakers from Washington University, and one or two outside investigators.
- It’s not necessary to suggest particular speakers for your topic but, if you have ideas, you’re welcome to include.
